Robert Corringham
Impact in
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Neutropenia and Cancer Infections
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 14
- Hematopoietic Stem Cell Transplantation 6
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 3
- Oncology 16
- Cancer Treatment and Pharmacology 4
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Mohit TrikhaJean‐François RossiBernard KleinMark DeWitteE. BoesenUma PrabhakarHilary BlacklockSusan Hoare
- Journals
- Journal of Antimicrobial Chemotherapy (4 papers)Blood (3 papers)Journal of Clinical Oncology (2 papers)The Lancet (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Robert Corringham
33 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 101
- Hematology 451
- Oncology 823
- Immunology 454
- Cancer Research 215
- Genetics 147
Countries citing papers authored by Robert Corringham
This map shows the geographic impact of Robert Corringham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Corringham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Corringham more than expected).
Fields of papers citing papers by Robert Corringham
This network shows the impact of papers produced by Robert Corringham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Corringham. The network helps show where Robert Corringham may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Robert Corringham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 54 | |
| 2 | A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. | 2008 | 122 |
| 3 | 2008 | 140 | |
| 4 | 2008 | 11 | |
| 5 | 2007 | 93 | |
| 6 | 2007 | 81 | |
| 7 | 2007 | 195 | |
| 8 | 2006 | 0 | |
| 9 | Are inflammatory cytokines the common link between cancer-associated cachexia and depression? | 2005 | 66 |
| 10 | 1999 | 12 | |
| 11 | 1998 | 6 | |
| 12 | 1996 | 40 | |
| 13 | 1994 | 2 | |
| 14 | 1993 | 6 | |
| 15 | 1988 | 9 | |
| 16 | 1984 | 2 | |
| 17 | 1982 | 126 | |
| 18 | 1979 | 132 | |
| 19 | 1978 | 17 | |
| 20 | 1977 | 11 |
About Robert Corringham
Robert Corringham is a scholar working on Hematology, Oncology, Applied Microbiology and Biotechnology, Genetics and Immunology and Allergy, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (6 papers), Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers), Immunotherapy and Immune Responses (3 papers), Acute Myeloid Leukemia Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (451 citations), Oncology (823 citations), Immunology (454 citations), Cancer Research (215 citations) and Genetics (147 citations). Robert Corringham has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Mohit Trikha, Jean‐François Rossi, Bernard Klein, Mark DeWitte, E. Boesen, Uma Prabhakar, Hilary Blacklock, Susan Hoare, Kellie A. Charles and H. G. Prentice. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Blood, Journal of Clinical Oncology, The Lancet and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.